Comparison of metoclopramide with Ondansetron for Treating Nausea
Phase 3
- Conditions
- ause.Nausea
- Registration Number
- IRCT20180717040509N1
- Lead Sponsor
- Sari University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
patients with Nausea sign
Exclusion Criteria
Age under 18 years
Pregnant patients
Patients with mental and physical disabilities
Patients with a history of allergy to study drugs
Patients with systolic blood pressure less than 90mmHg
Receive an anti-nausea medicine in the last 24 hours
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of nausea based on Visual ?Analog Scale. Timepoint: At the beginning of the study (before the injection) and 30 minutes after the injection of the drug. Method of measurement: Visual Analogue Scale.
- Secondary Outcome Measures
Name Time Method